3[3]Eshima D,Fauconnier T,Eshima L,et al.Radiopharmaceuticals for lymphoscintigraphy:including dosimetry and radiotion considerations.Semin Nucl Med,2000,30:25-32 被引量：1
4[4]Goldfarb LR,Alazrarki N,Eshima D,et al.Lymphoscintigraphic identification of sentinel lymph nodes:clinical evaluation of 0.22mm filtration of Tc-99m sulfur colloid.Radiology,1998,208:505-509 被引量：1
5[5]Linehan DC,Hill AD,Tran KN,et al.Sentinel lymph node biopsy in breast cancer:unfiltered radioisotope is superior to filled.J Am Coll Surg,1999,188:337-381 被引量：1
6[6]Goldberg BB,Forsberg F,Merton DA,et al.Conventional and delayed imaging using NCI00100:a new contrast agent (abstr).Radiology,1997,205(P):417 被引量：1
7[7]Forsberg F,Liu JB,Merton DA,et al.Gray scale second harmonic imaging of acoustic emission signals improves detection of liver tumors in rabbits.J Ultrasound Med,2000,19:557-563 被引量：1
8[8]Forsberg F,Piccoli CW,Liu JB,et al.Hepatic tumor detection:MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial systemspecific phase.Radiology,2002,222:824-829 被引量：1
9[9]Needleman L,Blomley MJ,Albrecht T,et al.Liver parenchyma contrast-enhanced ultrasound:preliminary results of a multicenter study for liver lesion detection(abstr.).Radiology,2000,217 (P):305 被引量：1
10[10]Needleman L,Blomley MJ,Albrecht T,et al.Detection of liver lesions with the US contrast agent Sonazoid:result of a multicenter study (abstr).J Ultrasound Med,2001,20:S11 被引量：1
